Segments of Business and Geographic Areas - Sales By Segment Of Business (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jul. 03, 2022	Jul. 04, 2021	Jul. 03, 2022	Jul. 04, 2021
Sales by segment of business
Sales to customers	$ 24,020	$ 23,312	$ 47,446	$ 45,633
Percent Change (as a percent)	3.00%		4.00%
U.S.
Sales by segment of business
Sales to customers	$ 12,197	11,919	$ 23,611	23,030
Percent Change (as a percent)	2.30%		2.50%
International
Sales by segment of business
Sales to customers	$ 11,823	11,393	$ 23,835	22,603
Percent Change (as a percent)	3.80%		5.50%
CONSUMER HEALTH (1)
Sales by segment of business
Sales to customers	$ 3,805	3,854	$ 7,391	7,495
Percent Change (as a percent)	(1.30%)		(1.40%)
CONSUMER HEALTH (1) | U.S.
Sales by segment of business
Sales to customers	$ 1,687	1,751	$ 3,244	3,362
Percent Change (as a percent)	(3.60%)		(3.50%)
CONSUMER HEALTH (1) | International
Sales by segment of business
Sales to customers	$ 2,118	2,103	$ 4,147	4,133
Percent Change (as a percent)	0.60%		0.30%
CONSUMER HEALTH (1) | OTC [Member]
Sales by segment of business
Sales to customers	$ 1,482	1,426	$ 2,943	2,699
Percent Change (as a percent)	3.80%		9.00%
CONSUMER HEALTH (1) | OTC [Member] | U.S.
Sales by segment of business
Sales to customers	$ 663	675	$ 1,333	1,274
Percent Change (as a percent)	(1.80%)		4.60%
CONSUMER HEALTH (1) | OTC [Member] | International
Sales by segment of business
Sales to customers	$ 818	752	$ 1,609	1,425
Percent Change (as a percent)	8.80%		12.90%
CONSUMER HEALTH (1) | Skin Health/Beauty
Sales by segment of business
Sales to customers	$ 1,126	1,170	$ 2,138	2,333
Percent Change (as a percent)	(3.70%)		(8.30%)
CONSUMER HEALTH (1) | Skin Health/Beauty | U.S.
Sales by segment of business
Sales to customers	$ 629	659	$ 1,173	1,293
Percent Change (as a percent)	(4.50%)		(9.20%)
CONSUMER HEALTH (1) | Skin Health/Beauty | International
Sales by segment of business
Sales to customers	$ 497	511	$ 965	1,040
Percent Change (as a percent)	(2.80%)		(7.20%)
CONSUMER HEALTH (1) | Oral Care
Sales by segment of business
Sales to customers	$ 394	426	$ 760	843
Percent Change (as a percent)	(7.30%)		(9.70%)
CONSUMER HEALTH (1) | Oral Care | U.S.
Sales by segment of business
Sales to customers	$ 170	165	$ 313	328
Percent Change (as a percent)	3.40%		(4.60%)
CONSUMER HEALTH (1) | Oral Care | International
Sales by segment of business
Sales to customers	$ 224	260	$ 447	514
Percent Change (as a percent)	(14.10%)		(13.00%)
CONSUMER HEALTH (1) | Baby Care
Sales by segment of business
Sales to customers	$ 375	387	$ 730	776
Percent Change (as a percent)	(3.10%)		(5.90%)
CONSUMER HEALTH (1) | Baby Care | U.S.
Sales by segment of business
Sales to customers	$ 88	97	$ 173	193
Percent Change (as a percent)	(9.10%)		(10.30%)
CONSUMER HEALTH (1) | Baby Care | International
Sales by segment of business
Sales to customers	$ 287	290	$ 557	583
Percent Change (as a percent)	(1.00%)		(4.40%)
CONSUMER HEALTH (1) | Women's Health
Sales by segment of business
Sales to customers	$ 230	230	$ 458	452
Percent Change (as a percent)	0.20%		1.40%
CONSUMER HEALTH (1) | Women's Health | U.S.
Sales by segment of business
Sales to customers	$ 3	3	$ 7	6
Percent Change (as a percent)	8.90%		8.10%
CONSUMER HEALTH (1) | Women's Health | International
Sales by segment of business
Sales to customers	$ 228	227	$ 452	446
Percent Change (as a percent)	0.10%		1.30%
CONSUMER HEALTH (1) | Wound Care/Other
Sales by segment of business
Sales to customers	$ 197	216	$ 361	393
Percent Change (as a percent)	(8.40%)		(8.00%)
CONSUMER HEALTH (1) | Wound Care/Other | U.S.
Sales by segment of business
Sales to customers	$ 133	153	$ 245	268
Percent Change (as a percent)	(12.70%)		(8.60%)
CONSUMER HEALTH (1) | Wound Care/Other | International
Sales by segment of business
Sales to customers	$ 65	64	$ 117	125
Percent Change (as a percent)	1.70%		(6.60%)
PHARMACEUTICAL(1)
Sales by segment of business
Sales to customers	$ 13,317	12,480	$ 26,186	24,581
Percent Change (as a percent)	6.70%		6.50%
PHARMACEUTICAL(1) | U.S.
Sales by segment of business
Sales to customers	$ 7,159	6,869	$ 13,791	13,315
Percent Change (as a percent)	4.20%		3.60%
PHARMACEUTICAL(1) | International
Sales by segment of business
Sales to customers	$ 6,158	5,611	$ 12,395	11,266
Percent Change (as a percent)	9.80%		10.00%
PHARMACEUTICAL(1) | Immunology
Sales by segment of business
Sales to customers	$ 4,411	4,231	$ 8,530	8,145
Percent Change (as a percent)	4.30%		4.70%
PHARMACEUTICAL(1) | Immunology | U.S.
Sales by segment of business
Sales to customers	$ 2,853	2,748	$ 5,354	5,161
Percent Change (as a percent)	3.80%		3.70%
PHARMACEUTICAL(1) | Immunology | International
Sales by segment of business
Sales to customers	$ 1,559	1,483	$ 3,176	2,984
Percent Change (as a percent)	5.10%		6.40%
PHARMACEUTICAL(1) | Immunology | REMICADE
Sales by segment of business
Sales to customers	$ 647	888	$ 1,310	1,665
Percent Change (as a percent)	(27.20%)		(21.40%)
PHARMACEUTICAL(1) | Immunology | REMICADE | U.S.
Sales by segment of business
Sales to customers	$ 391	540	$ 749	1,029
Percent Change (as a percent)	(27.40%)		(27.10%)
PHARMACEUTICAL(1) | Immunology | REMICADE | U.S. Exports
Sales by segment of business
Sales to customers	$ 44	93	$ 124	150
Percent Change (as a percent)	(53.00%)		(17.50%)
PHARMACEUTICAL(1) | Immunology | REMICADE | International
Sales by segment of business
Sales to customers	$ 212	255	$ 437	487
Percent Change (as a percent)	(17.20%)		(10.30%)
PHARMACEUTICAL(1) | Immunology | SIMPONI / SIMPONI ARIA
Sales by segment of business
Sales to customers	$ 566	584	$ 1,137	1,146
Percent Change (as a percent)	(3.00%)		(0.80%)
PHARMACEUTICAL(1) | Immunology | SIMPONI / SIMPONI ARIA | U.S.
Sales by segment of business
Sales to customers	$ 301	290	$ 588	545
Percent Change (as a percent)	3.80%		7.90%
PHARMACEUTICAL(1) | Immunology | SIMPONI / SIMPONI ARIA | International
Sales by segment of business
Sales to customers	$ 266	294	$ 549	601
Percent Change (as a percent)	(9.70%)		(8.60%)
PHARMACEUTICAL(1) | Immunology | STELARA
Sales by segment of business
Sales to customers	$ 2,599	2,274	$ 4,887	4,422
Percent Change (as a percent)	14.30%		10.50%
PHARMACEUTICAL(1) | Immunology | STELARA | U.S.
Sales by segment of business
Sales to customers	$ 1,731	1,496	$ 3,110	2,827
Percent Change (as a percent)	15.70%		10.00%
PHARMACEUTICAL(1) | Immunology | STELARA | International
Sales by segment of business
Sales to customers	$ 868	778	$ 1,777	1,595
Percent Change (as a percent)	11.60%		11.40%
PHARMACEUTICAL(1) | Immunology | TREMFYA
Sales by segment of business
Sales to customers	$ 597	479	$ 1,187	897
Percent Change (as a percent)	24.40%		32.30%
PHARMACEUTICAL(1) | Immunology | TREMFYA | U.S.
Sales by segment of business
Sales to customers	$ 382	325	$ 773	599
Percent Change (as a percent)	17.70%		29.10%
PHARMACEUTICAL(1) | Immunology | TREMFYA | International
Sales by segment of business
Sales to customers	$ 214	155	$ 413	298
Percent Change (as a percent)	38.30%		38.60%
PHARMACEUTICAL(1) | Immunology | OTHER IMMUNOLOGY
Sales by segment of business
Sales to customers	$ 3	7	$ 9	15
Percent Change (as a percent)	(59.20%)		(39.00%)
PHARMACEUTICAL(1) | Immunology | OTHER IMMUNOLOGY | U.S.
Sales by segment of business
Sales to customers	$ 3	5	$ 9	12
Percent Change (as a percent)	(50.10%)		(24.80%)
PHARMACEUTICAL(1) | Immunology | OTHER IMMUNOLOGY | International
Sales by segment of business
Sales to customers	$ 0	1	$ 0	3
PHARMACEUTICAL(1) | Infectious Diseases
Sales by segment of business
Sales to customers	$ 1,316	1,018	$ 2,613	2,016
Percent Change (as a percent)	29.30%		29.60%
PHARMACEUTICAL(1) | Infectious Diseases | U.S.
Sales by segment of business
Sales to customers	$ 415	444	$ 876	956
Percent Change (as a percent)	(6.40%)		(8.30%)
PHARMACEUTICAL(1) | Infectious Diseases | International
Sales by segment of business
Sales to customers	$ 901	575	$ 1,737	1,060
Percent Change (as a percent)	56.80%		63.90%
PHARMACEUTICAL(1) | Infectious Diseases | COVID-19
Sales by segment of business
Sales to customers	$ 544	164	$ 1,001	264
PHARMACEUTICAL(1) | Infectious Diseases | COVID-19 | U.S.
Sales by segment of business
Sales to customers	$ 45	51	$ 120	151
Percent Change (as a percent)	(11.50%)		(20.40%)
PHARMACEUTICAL(1) | Infectious Diseases | COVID-19 | International
Sales by segment of business
Sales to customers	$ 499	113	$ 881	113
PHARMACEUTICAL(1) | Infectious Diseases | EDURANT / rilpivirine
Sales by segment of business
Sales to customers	$ 225	262	$ 473	505
Percent Change (as a percent)	(14.30%)		(6.50%)
PHARMACEUTICAL(1) | Infectious Diseases | EDURANT / rilpivirine | U.S.
Sales by segment of business
Sales to customers	$ 9	9	$ 18	19
Percent Change (as a percent)	(1.70%)		(7.40%)
PHARMACEUTICAL(1) | Infectious Diseases | EDURANT / rilpivirine | International
Sales by segment of business
Sales to customers	$ 215	253	$ 454	486
Percent Change (as a percent)	(14.70%)		(6.50%)
PHARMACEUTICAL(1) | Infectious Diseases | PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA
Sales by segment of business
Sales to customers	$ 464	505	$ 965	1,051
Percent Change (as a percent)	(7.90%)		(8.10%)
PHARMACEUTICAL(1) | Infectious Diseases | PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA | U.S.
Sales by segment of business
Sales to customers	$ 355	368	$ 724	748
Percent Change (as a percent)	(3.40%)		(3.20%)
PHARMACEUTICAL(1) | Infectious Diseases | PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA | International
Sales by segment of business
Sales to customers	$ 110	137	$ 242	303
Percent Change (as a percent)	(20.20%)		(20.30%)
PHARMACEUTICAL(1) | Infectious Diseases | OTHER INFECTIOUS DISEASES(
Sales by segment of business
Sales to customers	$ 83	88	$ 174	196
Percent Change (as a percent)	(5.40%)		(10.90%)
PHARMACEUTICAL(1) | Infectious Diseases | OTHER INFECTIOUS DISEASES( | U.S.
Sales by segment of business
Sales to customers	$ 6	16	$ 14	37
Percent Change (as a percent)	(62.50%)		(62.50%)
PHARMACEUTICAL(1) | Infectious Diseases | OTHER INFECTIOUS DISEASES( | International
Sales by segment of business
Sales to customers	$ 77	71	$ 160	158
Percent Change (as a percent)	7.40%		1.30%
PHARMACEUTICAL(1) | Neuroscience
Sales by segment of business
Sales to customers	$ 1,734	1,804	$ 3,475	3,519
Percent Change (as a percent)	(3.90%)		(1.20%)
PHARMACEUTICAL(1) | Neuroscience | U.S.
Sales by segment of business
Sales to customers	$ 896	842	$ 1,739	1,613
Percent Change (as a percent)	6.50%		7.90%
PHARMACEUTICAL(1) | Neuroscience | International
Sales by segment of business
Sales to customers	$ 837	963	$ 1,735	1,906
Percent Change (as a percent)	(13.00%)		(8.90%)
PHARMACEUTICAL(1) | Neuroscience | CONCERTA / methylphenidate
Sales by segment of business
Sales to customers	$ 161	161	$ 318	332
Percent Change (as a percent)	0.30%		(4.10%)
PHARMACEUTICAL(1) | Neuroscience | CONCERTA / methylphenidate | U.S.
Sales by segment of business
Sales to customers	$ 38	35	$ 73	82
Percent Change (as a percent)	9.40%		(11.30%)
PHARMACEUTICAL(1) | Neuroscience | CONCERTA / methylphenidate | International
Sales by segment of business
Sales to customers	$ 123	127	$ 245	250
Percent Change (as a percent)	(2.20%)		(1.70%)
PHARMACEUTICAL(1) | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA
Sales by segment of business
Sales to customers	$ 1,054	1,024	$ 2,102	1,989
Percent Change (as a percent)	2.90%		5.70%
PHARMACEUTICAL(1) | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA | U.S.
Sales by segment of business
Sales to customers	$ 691	645	$ 1,352	1,234
Percent Change (as a percent)	7.30%		9.60%
PHARMACEUTICAL(1) | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA | International
Sales by segment of business
Sales to customers	$ 362	380	$ 749	756
Percent Change (as a percent)	(4.60%)		(0.80%)
PHARMACEUTICAL(1) | Neuroscience | RISPERDAL CONSTA
Sales by segment of business
Sales to customers	$ 125	155	$ 254	312
Percent Change (as a percent)	(19.30%)		(18.40%)
PHARMACEUTICAL(1) | Neuroscience | RISPERDAL CONSTA | U.S.
Sales by segment of business
Sales to customers	$ 65	72	$ 128	139
Percent Change (as a percent)	(8.90%)		(7.70%)
PHARMACEUTICAL(1) | Neuroscience | RISPERDAL CONSTA | International
Sales by segment of business
Sales to customers	$ 60	84	$ 126	173
Percent Change (as a percent)	(28.00%)		(27.10%)
PHARMACEUTICAL(1) | Neuroscience | OTHER NEUROSCIENCE
Sales by segment of business
Sales to customers	$ 393	464	$ 800	886
Percent Change (as a percent)	(15.20%)		(9.60%)
PHARMACEUTICAL(1) | Neuroscience | OTHER NEUROSCIENCE | U.S.
Sales by segment of business
Sales to customers	$ 102	91	$ 186	158
Percent Change (as a percent)	11.80%		17.60%
PHARMACEUTICAL(1) | Neuroscience | OTHER NEUROSCIENCE | International
Sales by segment of business
Sales to customers	$ 292	373	$ 615	728
Percent Change (as a percent)	(21.80%)		(15.50%)
PHARMACEUTICAL(1) | Oncology
Sales by segment of business
Sales to customers	$ 4,042	3,535	$ 7,992	7,105
Percent Change (as a percent)	14.30%		12.50%
PHARMACEUTICAL(1) | Oncology | U.S.
Sales by segment of business
Sales to customers	$ 1,679	1,462	$ 3,261	2,839
Percent Change (as a percent)	14.90%		14.90%
PHARMACEUTICAL(1) | Oncology | International
Sales by segment of business
Sales to customers	$ 2,362	2,073	$ 4,731	4,266
Percent Change (as a percent)	14.00%		10.90%
PHARMACEUTICAL(1) | Oncology | DARZALEX
Sales by segment of business
Sales to customers	$ 1,986	1,433	$ 3,842	2,798
Percent Change (as a percent)	38.60%		37.30%
PHARMACEUTICAL(1) | Oncology | DARZALEX | U.S.
Sales by segment of business
Sales to customers	$ 1,021	770	$ 1,974	1,461
Percent Change (as a percent)	32.60%		35.10%
PHARMACEUTICAL(1) | Oncology | DARZALEX | International
Sales by segment of business
Sales to customers	$ 965	663	$ 1,868	1,337
Percent Change (as a percent)	45.50%		39.70%
PHARMACEUTICAL(1) | Oncology | ERLEADA
Sales by segment of business
Sales to customers	$ 450	302	$ 850	563
Percent Change (as a percent)	49.50%		51.10%
PHARMACEUTICAL(1) | Oncology | ERLEADA | U.S.
Sales by segment of business
Sales to customers	$ 233	193	$ 439	364
Percent Change (as a percent)	20.60%		20.40%
PHARMACEUTICAL(1) | Oncology | ERLEADA | International
Sales by segment of business
Sales to customers	$ 218	109	$ 412	199
PHARMACEUTICAL(1) | Oncology | IMBRUVICA
Sales by segment of business
Sales to customers	$ 970	1,116	$ 2,008	2,241
Percent Change (as a percent)	(13.10%)		(10.40%)
PHARMACEUTICAL(1) | Oncology | IMBRUVICA | U.S.
Sales by segment of business
Sales to customers	$ 349	454	$ 719	898
Percent Change (as a percent)	(23.10%)		(19.90%)
PHARMACEUTICAL(1) | Oncology | IMBRUVICA | International
Sales by segment of business
Sales to customers	$ 620	662	$ 1,288	1,342
Percent Change (as a percent)	(6.30%)		(4.00%)
PHARMACEUTICAL(1) | Oncology | ZYTIGA / abiraterone acetate
Sales by segment of business
Sales to customers	$ 505	563	$ 1,044	1,201
Percent Change (as a percent)	(10.30%)		(13.10%)
PHARMACEUTICAL(1) | Oncology | ZYTIGA / abiraterone acetate | U.S.
Sales by segment of business
Sales to customers	$ 19	21	$ 38	71
Percent Change (as a percent)	(12.20%)		(47.00%)
PHARMACEUTICAL(1) | Oncology | ZYTIGA / abiraterone acetate | International
Sales by segment of business
Sales to customers	$ 486	542	$ 1,006	1,130
Percent Change (as a percent)	(10.20%)		(11.00%)
PHARMACEUTICAL(1) | Oncology | OTHER ONCOLOGY
Sales by segment of business
Sales to customers	$ 130	120	$ 248	302
Percent Change (as a percent)	7.50%		(18.00%)
PHARMACEUTICAL(1) | Oncology | OTHER ONCOLOGY | U.S.
Sales by segment of business
Sales to customers	$ 57	23	$ 91	44
PHARMACEUTICAL(1) | Oncology | OTHER ONCOLOGY | International
Sales by segment of business
Sales to customers	$ 72	97	$ 156	258
Percent Change (as a percent)	(25.70%)		(39.40%)
PHARMACEUTICAL(1) | Pulmonary Hypertension
Sales by segment of business
Sales to customers	$ 843	870	$ 1,695	1,731
Percent Change (as a percent)	(3.10%)		(2.10%)
PHARMACEUTICAL(1) | Pulmonary Hypertension | U.S.
Sales by segment of business
Sales to customers	$ 560	595	$ 1,132	1,168
Percent Change (as a percent)	(5.80%)		(3.10%)
PHARMACEUTICAL(1) | Pulmonary Hypertension | International
Sales by segment of business
Sales to customers	$ 284	275	$ 563	563
Percent Change (as a percent)	2.80%		(0.10%)
PHARMACEUTICAL(1) | Pulmonary Hypertension | OPSUMIT
Sales by segment of business
Sales to customers	$ 438	463	$ 881	913
Percent Change (as a percent)	(5.30%)		(3.50%)
PHARMACEUTICAL(1) | Pulmonary Hypertension | OPSUMIT | U.S.
Sales by segment of business
Sales to customers	$ 265	290	$ 538	562
Percent Change (as a percent)	(8.70%)		(4.30%)
PHARMACEUTICAL(1) | Pulmonary Hypertension | OPSUMIT | International
Sales by segment of business
Sales to customers	$ 173	172	$ 343	351
Percent Change (as a percent)	0.50%		(2.20%)
PHARMACEUTICAL(1) | Pulmonary Hypertension | UPTRAVI
Sales by segment of business
Sales to customers	$ 328	313	$ 653	618
Percent Change (as a percent)	4.90%		5.70%
PHARMACEUTICAL(1) | Pulmonary Hypertension | UPTRAVI | U.S.
Sales by segment of business
Sales to customers	$ 272	268	$ 541	527
Percent Change (as a percent)	1.40%		2.60%
PHARMACEUTICAL(1) | Pulmonary Hypertension | UPTRAVI | International
Sales by segment of business
Sales to customers	$ 56	45	$ 112	91
Percent Change (as a percent)	26.20%		23.50%
PHARMACEUTICAL(1) | Pulmonary Hypertension | Other
Sales by segment of business
Sales to customers	$ 78	95	$ 161	200
Percent Change (as a percent)	(18.70%)		(19.80%)
PHARMACEUTICAL(1) | Pulmonary Hypertension | Other | U.S.
Sales by segment of business
Sales to customers	$ 23	36	$ 53	78
Percent Change (as a percent)	(36.20%)		(32.30%)
PHARMACEUTICAL(1) | Pulmonary Hypertension | Other | International
Sales by segment of business
Sales to customers	$ 55	59	$ 108	122
Percent Change (as a percent)	(8.10%)		(11.70%)
PHARMACEUTICAL(1) | Cardiovascular / Metabolism / Other
Sales by segment of business
Sales to customers	$ 972	1,021	$ 1,882	2,065
Percent Change (as a percent)	(4.80%)		(8.90%)
PHARMACEUTICAL(1) | Cardiovascular / Metabolism / Other | U.S.
Sales by segment of business
Sales to customers	$ 757	780	$ 1,429	1,579
Percent Change (as a percent)	(3.00%)		(9.50%)
PHARMACEUTICAL(1) | Cardiovascular / Metabolism / Other | International
Sales by segment of business
Sales to customers	$ 215	241	$ 453	486
Percent Change (as a percent)	(10.90%)		(6.90%)
PHARMACEUTICAL(1) | Cardiovascular / Metabolism / Other | XARELTO
Sales by segment of business
Sales to customers	$ 609	569	$ 1,117	1,158
Percent Change (as a percent)	7.10%		(3.50%)
PHARMACEUTICAL(1) | Cardiovascular / Metabolism / Other | XARELTO | U.S.
Sales by segment of business
Sales to customers	$ 609	569	$ 1,117	1,158
Percent Change (as a percent)	7.10%		(3.50%)
PHARMACEUTICAL(1) | Cardiovascular / Metabolism / Other | XARELTO | International
Sales by segment of business
Sales to customers	$ 0	0	$ 0	0
Percent Change (as a percent)	0.00%		0.00%
PHARMACEUTICAL(1) | Cardiovascular / Metabolism / Other | INVOKANA / INVOKAMET
Sales by segment of business
Sales to customers	$ 120	160	$ 248	310
Percent Change (as a percent)	(24.90%)		(19.90%)
PHARMACEUTICAL(1) | Cardiovascular / Metabolism / Other | INVOKANA / INVOKAMET | U.S.
Sales by segment of business
Sales to customers	$ 55	96	$ 115	183
Percent Change (as a percent)	(42.90%)		(37.10%)
PHARMACEUTICAL(1) | Cardiovascular / Metabolism / Other | INVOKANA / INVOKAMET | International
Sales by segment of business
Sales to customers	$ 65	64	$ 133	127
Percent Change (as a percent)	2.40%		4.90%
PHARMACEUTICAL(1) | Cardiovascular / Metabolism / Other | Other
Sales by segment of business
Sales to customers	$ 243	293	$ 517	598
Percent Change (as a percent)	(17.20%)		(13.50%)
PHARMACEUTICAL(1) | Cardiovascular / Metabolism / Other | Other | U.S.
Sales by segment of business
Sales to customers	$ 93	116	$ 197	238
Percent Change (as a percent)	(19.50%)		(17.20%)
PHARMACEUTICAL(1) | Cardiovascular / Metabolism / Other | Other | International
Sales by segment of business
Sales to customers	$ 150	178	$ 320	360
Percent Change (as a percent)	(15.60%)		(11.10%)
MEDTECH(3)
Sales by segment of business
Sales to customers	$ 6,898	6,978	$ 13,869	13,557
Percent Change (as a percent)	(1.10%)		2.30%
MEDTECH(3) | U.S.
Sales by segment of business
Sales to customers	$ 3,351	3,299	$ 6,576	6,353
Percent Change (as a percent)	1.60%		3.50%
MEDTECH(3) | International
Sales by segment of business
Sales to customers	$ 3,547	3,679	$ 7,293	7,204
Percent Change (as a percent)	(3.60%)		1.20%
MEDTECH(3) | Interventional Solutions
Sales by segment of business
Sales to customers	$ 1,049	1,046	$ 2,141	1,995
Percent Change (as a percent)	0.30%		7.40%
MEDTECH(3) | Interventional Solutions | U.S.
Sales by segment of business
Sales to customers	$ 525	475	$ 1,019	909
Percent Change (as a percent)	10.50%		12.10%
MEDTECH(3) | Interventional Solutions | International
Sales by segment of business
Sales to customers	$ 525	572	$ 1,123	1,086
Percent Change (as a percent)	(8.10%)		3.40%
MEDTECH(3) | Orthopaedics
Sales by segment of business
Sales to customers	$ 2,157	2,227	$ 4,345	4,340
Percent Change (as a percent)	(3.10%)		0.10%
MEDTECH(3) | Orthopaedics | U.S.
Sales by segment of business
Sales to customers	$ 1,338	1,323	$ 2,627	2,572
Percent Change (as a percent)	1.10%		2.10%
MEDTECH(3) | Orthopaedics | International
Sales by segment of business
Sales to customers	$ 820	904	$ 1,719	1,768
Percent Change (as a percent)	(9.30%)		(2.80%)
MEDTECH(3) | Orthopaedics | HIPS
Sales by segment of business
Sales to customers	$ 388	391	$ 777	747
Percent Change (as a percent)	(0.70%)		4.10%
MEDTECH(3) | Orthopaedics | HIPS | U.S.
Sales by segment of business
Sales to customers	$ 240	233	$ 465	442
Percent Change (as a percent)	3.40%		5.20%
MEDTECH(3) | Orthopaedics | HIPS | International
Sales by segment of business
Sales to customers	$ 148	159	$ 312	305
Percent Change (as a percent)	(6.60%)		2.40%
MEDTECH(3) | Orthopaedics | KNEES
Sales by segment of business
Sales to customers	$ 349	350	$ 688	667
Percent Change (as a percent)	(0.10%)		3.10%
MEDTECH(3) | Orthopaedics | KNEES | U.S.
Sales by segment of business
Sales to customers	$ 216	210	$ 417	395
Percent Change (as a percent)	2.90%		5.60%
MEDTECH(3) | Orthopaedics | KNEES | International
Sales by segment of business
Sales to customers	$ 133	140	$ 271	272
Percent Change (as a percent)	(4.60%)		(0.40%)
MEDTECH(3) | Orthopaedics | TRAUMA
Sales by segment of business
Sales to customers	$ 696	710	$ 1,444	1,443
Percent Change (as a percent)	(1.90%)		0.10%
MEDTECH(3) | Orthopaedics | TRAUMA | U.S.
Sales by segment of business
Sales to customers	$ 464	447	$ 939	897
Percent Change (as a percent)	3.90%		4.70%
MEDTECH(3) | Orthopaedics | TRAUMA | International
Sales by segment of business
Sales to customers	$ 232	263	$ 505	545
Percent Change (as a percent)	(11.80%)		(7.40%)
MEDTECH(3) | Orthopaedics | SPINE, SPORTS & OTHER
Sales by segment of business
Sales to customers	$ 724	777	$ 1,436	1,484
Percent Change (as a percent)	(6.80%)		(3.20%)
MEDTECH(3) | Orthopaedics | SPINE, SPORTS & OTHER | U.S.
Sales by segment of business
Sales to customers	$ 418	434	$ 805	838
Percent Change (as a percent)	(3.70%)		(3.90%)
MEDTECH(3) | Orthopaedics | SPINE, SPORTS & OTHER | International
Sales by segment of business
Sales to customers	$ 306	343	$ 630	646
Percent Change (as a percent)	(10.60%)		(2.40%)
MEDTECH(3) | Surgery
Sales by segment of business
Sales to customers	$ 2,450	2,522	$ 4,884	4,894
Percent Change (as a percent)	(2.80%)		(0.20%)
MEDTECH(3) | Surgery | U.S.
Sales by segment of business
Sales to customers	$ 992	1,035	$ 1,913	1,933
Percent Change (as a percent)	(4.10%)		(1.00%)
MEDTECH(3) | Surgery | International
Sales by segment of business
Sales to customers	$ 1,458	1,487	$ 2,971	2,961
Percent Change (as a percent)	(2.00%)		0.30%
MEDTECH(3) | Surgery | ADVANCED
Sales by segment of business
Sales to customers	$ 1,156	1,168	$ 2,302	2,286
Percent Change (as a percent)	(1.00%)		0.70%
MEDTECH(3) | Surgery | ADVANCED | U.S.
Sales by segment of business
Sales to customers	$ 454	459	$ 871	864
Percent Change (as a percent)	(1.10%)		0.80%
MEDTECH(3) | Surgery | ADVANCED | International
Sales by segment of business
Sales to customers	$ 702	708	$ 1,431	1,421
Percent Change (as a percent)	(0.90%)		0.70%
MEDTECH(3) | Surgery | GENERAL
Sales by segment of business
Sales to customers	$ 1,294	1,354	$ 2,582	2,608
Percent Change (as a percent)	(4.50%)		(1.00%)
MEDTECH(3) | Surgery | GENERAL | U.S.
Sales by segment of business
Sales to customers	$ 538	576	$ 1,042	1,069
Percent Change (as a percent)	(6.40%)		(2.50%)
MEDTECH(3) | Surgery | GENERAL | International
Sales by segment of business
Sales to customers	$ 756	779	$ 1,540	1,540
Percent Change (as a percent)	(3.00%)		0.00%
MEDTECH(3) | Vision
Sales by segment of business
Sales to customers	$ 1,241	1,183	$ 2,498	2,328
Percent Change (as a percent)	4.90%		7.30%
MEDTECH(3) | Vision | U.S.
Sales by segment of business
Sales to customers	$ 496	467	$ 1,017	939
Percent Change (as a percent)	6.20%		8.30%
MEDTECH(3) | Vision | International
Sales by segment of business
Sales to customers	$ 745	716	$ 1,481	1,389
Percent Change (as a percent)	4.00%		6.60%
MEDTECH(3) | Vision | CONTACT LENSES / OTHER
Sales by segment of business
Sales to customers	$ 894	868	$ 1,804	1,725
Percent Change (as a percent)	2.90%		4.50%
MEDTECH(3) | Vision | CONTACT LENSES / OTHER | U.S.
Sales by segment of business
Sales to customers	$ 374	352	$ 774	723
Percent Change (as a percent)	6.60%		7.20%
MEDTECH(3) | Vision | CONTACT LENSES / OTHER | International
Sales by segment of business
Sales to customers	$ 519	517	$ 1,030	1,003
Percent Change (as a percent)	0.40%		2.70%
MEDTECH(3) | Vision | SURGICAL
Sales by segment of business
Sales to customers	$ 347	314	$ 694	602
Percent Change (as a percent)	10.50%		15.20%
MEDTECH(3) | Vision | SURGICAL | U.S.
Sales by segment of business
Sales to customers	$ 122	115	$ 243	216
Percent Change (as a percent)	5.10%		12.10%
MEDTECH(3) | Vision | SURGICAL | International
Sales by segment of business
Sales to customers	$ 225	199	$ 451	386
Percent Change (as a percent)	13.60%		17.00%
CONSUMER HEALTH and PHARMACEUTICAL [Member] | OTC [Member] | CHINA
Sales by segment of business
Sales to customers		$ 100		$ 200